Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Receivables (2024 - 2025)

Historic Change in Receivables for Gossamer Bio (GOSS) over the last 2 years, with Q3 2025 value amounting to $1.7 million.

  • Gossamer Bio's Change in Receivables fell 4376.48% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 5969.95%. This contributed to the annual value of $5.3 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Gossamer Bio's Change in Receivables is $1.7 million, which was down 4376.48% from $996000.0 recorded in Q2 2025.
  • Gossamer Bio's Change in Receivables' 5-year high stood at $3.6 million during Q2 2024, with a 5-year trough of -$1.2 million in Q4 2024.